Key result
Higher remnant cholesterol inflammatory index linked to ~7% increased CVD risk in early CKM syndrome.
Why the study?
Does a higher remnant cholesterol inflammatory index (RCII) predict incident cardiovascular disease in adults with early CKM syndrome?
Cohort (n=5,961)
Yes
Does a higher remnant cholesterol inflammatory index (RCII) predict incident cardiovascular disease in adults with early CKM syndrome?
Higher remnant cholesterol inflammatory index (RCII) is modestly associated with incident cardiovascular disease in adults with early CKM syndrome, highlighting its potential as an early risk stratification marker.
Answers are grounded in this paper and cite their sources.
May support RCII for early CKM risk stratification; leaves open added value beyond standard factors and requires validation.
BACKGROUND: Remnant cholesterol and systemic inflammation are two key, interrelated pathways in atherosclerosis. We examined whether the remnant cholesterol inflammatory index (RCII; remnant cholesterol × C-reactive protein/10) predicts incident cardiovascular disease (CVD) among adults in early cardiovascular-kidney-metabolic (CKM) stages. METHODS: We analyzed 5,961 China Health and Retirement Longitudinal Study participants aged ≥ 45 years (baseline 2015; follow-up through 2020) classified as CKM stages 0-3 and free of baseline CVD. Incident CVD (heart disease or stroke) was identified from self-reported physician diagnoses. We used multivariable Cox models with hierarchical adjustment, assessed dose-response patterns using restricted cubic splines, and conducted prespecified subgroup and exploratory mediation analyses. RESULTS: Over a median follow-up of 5.00 years (IQR, 5.00-5.09), 1,080 incident CVD occurred (18.1%). Each 1-unit increase in log-RCII was associated with higher CVD risk in the fully adjusted model (hazard ratio [HR] 1.070, 95% CI 1.016-1.127; P = 0.010). Compared with quartile 1, quartile 4 had increased risk (HR 1.239, 95% CI 1.029-1.492; P = 0.024; P for trend = 0.043). The dose-response association was linear (P for nonlinearity = 0.795), and no effect modification was detected (all P for interaction > 0.05). Systolic blood pressure mediated 5.0% (95% CI 1.10% to 17.00%) of the RCII-CVD association. CONCLUSIONS: Higher RCII was modestly associated with incident CVD across early CKM stages, suggesting a simple research marker to identify individuals at higher risk during a prevention window. Standardized thresholds and external validation of incremental predictive value are needed before clinical use.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted a cohort in Early cardiovascular-kidney-metabolic (CKM) syndrome (n=5,961). Remnant cholesterol inflammatory index (RCII) vs. Lower RCII levels was evaluated on Incident cardiovascular disease (heart disease or stroke) (HR 1.070, 95% CI 1.016-1.127, p=0.010). Each 1-unit increase in log-transformed remnant cholesterol inflammatory index was associated with a higher risk of incident cardiovascular disease among adults in early CKM stages.
Synapse has enriched 10 related papers. Consider them for comparative context: